Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Spondylitis, Ankylosing; Spondyloarthritis; Systemic Lupus Erythematosus; Sjogren's Syndrome; Systemic Sclerosis; Idiopathic Inflammatory Myopathies; Vasculitis, Systemic; Juvenile Idiopathic Arthritis; Dermatomyositis, Juvenile Interventions: Biological: Recombinant Herpes Zoster Vaccine (RZV); Other: MTX Discontinuation; Other: MMF Discontinuation; Other: Placebo; Other: MTX maintain; Other: MMF maintain Sponsors: University of Sao Paulo General Hospital; GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials
A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Conditions: Herpes Zoster (HZ); Shingles; Infectious Disease Interventions: Biological: JCXH-105; Biological: Active Control (Shingrix) Sponsors: Immorna Biotherapeutics, Inc.; ICON plc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2023 Category: Research Source Type: clinical trials
